Vitamin D status and clinical outcomes in incident dialysis patients: Results from the NECOSAD study

Nephrology Dialysis Transplantation

Volumn 26, Issue 3, 2011, Pages 1024-1032

  Drechsler, Christiane ^a,b   Verduijn, Marion ^a   Pilz, Stefan ^c,h   Dekker, Friedo W ^a   Krediet, Raymond T ^d   Ritz, Eberhard ^e   Wanner, Christoph ^b   Boeschoten, Elisabeth W ^f   Brandenburg, Vincent ^g  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f Hans Mak Institute   (Netherlands)

^g RWTH AACHEN UNIVERSITY   (Germany)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cardiovascular; dialysis; epidemiology; mortality; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; PARATHYROID HORMONE; VITAMIN D;

ADULT; AGED; ANEURYSM RUPTURE; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; EUROPE; FEMALE; HAZARD RATIO; HEART ARREST; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERKALEMIA; HYPERVOLEMIA; HYPOKALEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; NETHERLANDS; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; RISK FACTOR; TREATMENT DURATION; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 79952166216     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq606     Document Type: Article

References (37)

1. Barreto DV, Baretto FC, Liabeuf S et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol 2009;4:1128-1135
2. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281
3. Jacob AI, Sallman A, Santz Z et al. Defective photoproduction of cholecalciferol in normal and uremic humans. J Nutr 1984;114:1313-1319
4. Mehrotra R, Kermah DA, Salusky IB et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 2009;76:931-933
5. Pecovnik-Balon B, Jakopin E, Bevc S et al. Vitamin D and mortality as a novel nontraditional risk factor for mortality in hemodialysis patients. Ther Apher Dial 2009;13:268-272
6. Ravani P, Malberti F, Tripepi G et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009;75:88-95
7. Wang AY, Lam CW, Sanderson JE et al. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr 2008;87:1631-1638 (Pubitemid 351872624)
8. Wolf M, Shah A, Gutierrez O et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007;72:1004-1013 (Pubitemid 47530570)
9. Bouillon R, Carmeliet G, Verlinden L et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008;29:726-776
10. Peterlik M, Cross HS. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 2005;35:290-304 (Pubitemid 40675603)
11. Merkus MP, Jager KJ, Dekker FW et al. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis 1997;29:584-592 (Pubitemid 27155281)
12. Noordzij M, Korevaar JC, Bos WJ et al. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant 2006;21:2513-2520 (Pubitemid 44644525)
13. Southern DA, Faris PD, Brant R. Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol 2006;59:1110-1114 (Pubitemid 44374316)
14. Satagopan JM, Ben-Porat L, Berwick M et al. A note on competing risks in survival data analysis. Br J Cancer 2004;91:1229-1235 (Pubitemid 39424779)
15. Chonchol M, Cigolini M, Targher G. Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. Nephrol Dial Transplant 2008;23:269-274 (Pubitemid 351767364)
16. Matias PJ, Ferreira C, Jorge C et al. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant 2009;24:611-618
17. Pilz S, Tomaschitz A, Obermayer-Pietsch B et al. Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res 2009;29:3699-3704
18. Yamshchikov AV, Desai NS, Blumberg H et al. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract 2009;15:438-449
19. Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008;4:404-412
20. Doorenbos CR, van den Born J, Navis G et al. Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol 2009;5:691-700
21. Melamed ML, Astor B, Michos ED et al. 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol 2009;20:2631-2639
22. Kalantar-Zadeh K, Kovesdy CP. Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease. Clin J Am Soc Nephrol 2009;4:1529-1539
23. Tentori F, Albert JM, Young EW et al. The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2009;24:963-972
24. Kaisar MD, Isbel NM, Johnson DW. Recent clinical trials of pharmacologic cardiovascular interventions in patients with chronic kidney disease. Rev Recent Clin Trials 2008;3:79-88
25. Jean G, Terrat JC, Vanel T et al. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol Dial Transplant 2008;23:3670-3676
26. Jean G, Souberbielle JC, Chazot C. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant 2009;24:3799-3805
27. Mehrotra R, Kermah D, Budoff M et al. Hypovitaminosis in chronic kidney disease. Clin J Am Soc Nephrol 2008;3:1144-1151
28. Pittas AG, Lau J, Hu FB et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-2029 (Pubitemid 46997093)
29. Pilz S, Tomaschitz A, Ritz E et al. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 2009;6:621-630
30. Zittermann A, Schleithoff SS, Koerfer R. Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev 2006;11:25-33 (Pubitemid 43986205)
31. Pilz S, März W, Wellnitz B et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cohort of patients referred for coronary angiography. J Clin Endocrinol Metab 2008;93:3927-3935
32. Bodyak N, Ayus JC, Achinger S et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci USA 2007;104:16810-16815 (Pubitemid 350210947)
33. Tishkoff DX, Nibbelink KA, Holmberg KH et al. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 2008;149:558-564 (Pubitemid 351159356)
34. Pilz S, Tomaschitz A, Drechsler C et al. Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr Drug Targets 2010 Aug. 27. Epub ahead of print
35. Hathcock JN, Shao A, Vieth R et al. Risk assessment for vitamin D. Am J Clin Nutr 2007;85:6-18 (Pubitemid 46067609)
36. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-1737 (Pubitemid 47403059)
37. Gutierrez OM, Mannstadt M, Isakov T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008;359:584-592